Global Status of Approved Genetically Modified Plants

Global Status of Approved Genetically Modified Plants

All of the information contained within this document is based on data obtained from a  global database of genetically modified plants. As indicated elsewhere, the reader should be aware that this database includes not only plants produced using recombinant DNA techniques (e.g.,genetically engineered or transgenic plants), but also plants with novel traits that may have been produced using more traditional methods, such as accelerated mutagenesis or plant breeding. These latter plants are only regulated in Canada. (We suggest that you bookmark the page.)

The following table provides a listing of novel traits by crop species. In each case, the number of events with a particular trait is also provided. For additional information on each crop x trait combination, follow the relevant link under the “Crop Name” column.

Currently approved genetically modified plants have been developed to express one, or more, of the following basic phenotypic characteristics: Agronomic performance;  Amino acid composition;  Fatty acid composition;  Fertility restoration;  Herbicide tolerance;  Insect resistance;  Lepidopteran resistance;  Male sterility;  Modified color;  Mutations;  Nicotine reduced;  Plant quality;  Ripening delayed;  Selectable marker;  Starch hydrolysis;  Virus resistance;

The following table correlates these traits with the genes, including their sources, that have been incorporated into plants in either native or modified form. In cases where modified plants have been produced via traditional cross-breeding or accelerated mutagenesis techniques, the mutated or target genes are indicated, where known. For additional information on each trait x genetic element combination, follow the highlighted links under the “Trait” heading.

The following table provides a summary of the regulatory approval status for each genetically modified crop. Follow the highlighted links under the “Crop” column to view detailed information for each approved event.

Issues surrounding Genetically Modified Plants

“The first reported recombination of genetic material was in 1973, so this technology is just over 30 years old. One of the first applications was the production of insulin by bacteria (insulin to be used for treating diabetics was previously derived from pig pancreas); the recombinant insulin product was approved by the FDA in 1982. The bacteria used for this purpose is a strain of E. coli, a common organism (it is a major bacteria in the human intestinal tract), into which the human insulin gene is inserted. The advantage of this technology is that the product matches human insulin exactly and it is cheaper to produce; the pig product is more likely to cause allergic reactions.

http://www.itmonline.org/arts/gmo.htm

Please follow and like us:

18849

7586339647

988k

72349